Sutro Biopharma Inc (FRA:S090)
€ 20.6 -1 (-4.63%) Market Cap: 305.96 Mil Enterprise Value: 172.93 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Sutro Biopharma Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript

May 27, 2026 / 04:30 PM GMT
Release Date Price: €32.2


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

STRO.OQ - Sutro Biopharma Inc
Sutro Biopharma Inc at TD Cowen Oncology Innovation Summit (Virtual)
May 27, 2026 / 04:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, everyone. I'm Tara Bancroft, one of the senior biotech analysts here at TD Cowan. And thank you so much for joining our seventh annual Oncology Summit ahead of ASCO. For our next session, we have a Q&A with Sutro. And it's my pleasure to introduce Jane Chung, the CEO of Sutro, and Hans-Peter Gerber, the Chief Scientific Officer. So, Jane and Hans-Peter, it is a privilege to have you both here as always. And thank you so much for joining me.

So, before I get started on Q&A, for those of you in the audience, you can e-mail me at [email protected] if you have a question or you can use the website. I forgot what it's called.

Whatever it is to submit your
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot